Sofinnova Investments’s InflaRx IFRX Stock Holding History

Sofinnova Investments’s Portfolio IFRX Stock Details IFRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,161,736	Closed	-$5.53M	–	71
2021 Q4	$5.53M	Buy	+1,161,736	New	+$4.67M	0.32%	52

Other funds holding IFRX

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Sofinnova Investments's IFRX Position: Q1 2022 in Review

Sofinnova Investments sold out of InflaRx (IFRX) in Q1 2022, closing a stake of 1,161,736 shares — an estimated $5.53M sold.

Sofinnova Investments first reported a position in IFRX in Q4 2021 and held it in 1 quarter. The position peaked at $5.53M in Q4 2021. 32 funds tracked by Wall St. Rank hold IFRX as of Q1 2022.

Sofinnova Investments reported no remaining InflaRx position as of Q1 2022 after selling out during the quarter.
Sofinnova Investments sold 1,161,736 InflaRx shares in Q1 2022, an estimated $5.53M.
Sofinnova Investments first reported a position in InflaRx in Q4 2021 and held it in 1 quarter.
Sofinnova Investments's InflaRx position peaked at $5.53M in Q4 2021.
32 funds tracked by Wall St. Rank held InflaRx as of Q1 2022.

Based on Sofinnova Investments's 13F filing for Q1 2022, filed 16 May 2022.